{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:14:46Z","timestamp":1787890486435,"version":"build-2784847793"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,26]]},"DOI":"10.7759\/cureus.95420","type":"journal-article","created":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:12:25Z","timestamp":1761466345000},"source":"Crossref","is-referenced-by-count":1,"title":["A Longitudinal Multicenter Study Comparing the Effectiveness of Pharmacological and Lifestyle-Only Interventions in Adults With Prediabetes for Preventing Acute Hyperglycemic Crises and Progression to Type 2 Diabetes Mellitus"],"prefix":"10.7759","author":[{"given":"Tauseef Ullah","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha","family":"Masood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Hassaan","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibte","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Tu Zuhra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iqra","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Hamza","family":"Ghufran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Usman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundas","family":"Safdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheema","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naqeeb","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v6.i2.296","article-title":"Prediabetes diagnosis and treatment: a review","volume":"6","author":"Bansal N","year":"2015","unstructured":"Bansal N. Prediabetes diagnosis and treatment: a review. World J Diabetes. 2015, 6:296-303. 10.4239\/wjd.v6.i2.296","journal-title":"World J Diabetes"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/dc05-2179","article-title":"Contributions of \u03b2-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose","volume":"29","author":"Abdul-Ghani MA","year":"2006","unstructured":"Abdul-Ghani MA, Tripathy D, Defronzo RA. Contributions of \u03b2-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006, 29:1130-9. 10.2337\/dc05-2179","journal-title":"Diabetes Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-015-0631-4","article-title":"Nutrition transition and the global diabetes epidemic","volume":"15","author":"Popkin BM","year":"2015","unstructured":"Popkin BM. Nutrition transition and the global diabetes epidemic. Curr Diab Rep. 2015, 15:64. 10.1007\/s11892-015-0631-4","journal-title":"Curr Diab Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60283-9","article-title":"Prediabetes: a high-risk state for diabetes development","volume":"379","author":"Tab\u00e1k AG","year":"2012","unstructured":"Tab\u00e1k AG, Herder C, Rathmann W, Brunner EJ, Kivim\u00e4ki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012, 379:2279-90. 10.1016\/S0140-6736(12)60283-9","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-090419-102644","article-title":"Prediabetes and what it means: the epidemiological evidence","volume":"42","author":"Echouffo-Tcheugui JB","year":"2021","unstructured":"Echouffo-Tcheugui JB, Selvin E. Prediabetes and what it means: the epidemiological evidence. Annu Rev Public Health. 2021, 42:59-77. 10.1146\/annurev-publhealth-090419-102644","journal-title":"Annu Rev Public Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.4.742","article-title":"The prevention or delay of type 2 diabetes","volume":"25","author":"American Diabetes Association","year":"2002","unstructured":"American Diabetes Association. The prevention or delay of type 2 diabetes. Diabetes Care. 2002, 25:742-9. 10.2337\/diacare.25.4.742","journal-title":"Diabetes Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-015-0155-x","article-title":"Weight loss and the prevention and treatment of type 2 diabetes using lifestyle therapy, pharmacotherapy, and bariatric surgery: mechanisms of action","volume":"4","author":"Grams J","year":"2015","unstructured":"Grams J, Garvey WT. Weight loss and the prevention and treatment of type 2 diabetes using lifestyle therapy, pharmacotherapy, and bariatric surgery: mechanisms of action. Curr Obes Rep. 2015, 4:287-302. 10.1007\/s13679-015-0155-x","journal-title":"Curr Obes Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.8.2067","article-title":"Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies: a statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition","volume":"27","author":"Klein S","year":"2004","unstructured":"Klein S, Sheard NF, Pi-Sunyer X, Daly A, Wylie-Rosett J, Kulkarni K, Clark NG. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies: a statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Diabetes Care. 2004, 27:2067-73. 10.2337\/diacare.27.8.2067","journal-title":"Diabetes Care"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2195","article-title":"Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis","volume":"37","author":"Dunkley AJ","year":"2014","unstructured":"Dunkley AJ, Bodicoat DH, Greaves CJ, Russell C, Yates T, Davies MJ, Khunti K. Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care. 2014, 37:922-33. 10.2337\/dc13-2195","journal-title":"Diabetes Care"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v15.i5.828","article-title":"Insulin therapy in type 2 diabetes: insights into clinical efficacy, patient-reported outcomes, and adherence challenges","volume":"15","author":"Emad-Eldin M","year":"2024","unstructured":"Emad-Eldin M, Balata GF, Elshorbagy EA, Hamed MS, Attia MS. Insulin therapy in type 2 diabetes: insights into clinical efficacy, patient-reported outcomes, and adherence challenges. World J Diabetes. 2024, 15:828-52. 10.4239\/wjd.v15.i5.828","journal-title":"World J Diabetes"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.23471","article-title":"Sociodemographic, clinical, and treatment-related factors associated with hyperglycemic crises among adults with type 1 or type 2 diabetes in the US from 2014 to 2020","volume":"4","author":"McCoy RG","year":"2021","unstructured":"McCoy RG, Galindo RJ, Swarna KS, Van Houten HK, O'Connor PJ, Umpierrez GE, Shah ND. Sociodemographic, clinical, and treatment-related factors associated with hyperglycemic crises among adults with type 1 or type 2 diabetes in the US from 2014 to 2020. JAMA Netw Open. 2021, 4:e2123471. 10.1001\/jamanetworkopen.2021.23471","journal-title":"JAMA Netw Open"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.10.1737","article-title":"A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes","volume":"25","author":"Viberti G","year":"2002","unstructured":"Viberti G, Kahn SE, Greene DA, et al.. A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes. Diabetes Care. 2002, 25:1737-43. 10.2337\/diacare.25.10.1737","journal-title":"Diabetes Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.4.888","article-title":"Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program","volume":"28","author":"Ratner R","year":"2005","unstructured":"Ratner R, Goldberg R, Haffner S, Marcovina S, Orchard T, Fowler S, Temprosa M. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care. 2005, 28:888-94. 10.2337\/diacare.28.4.888","journal-title":"Diabetes Care"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30093-2","article-title":"Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study","volume":"7","author":"Gong Q","year":"2019","unstructured":"Gong Q, Zhang P, Wang J, et al.. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study. Lancet Diabetes Endocrinol. 2019, 7:452-61. 10.1016\/S2213-8587(19)30093-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3126\/jdean.v3i1.24060","article-title":"Cost of illness study of regular out patient department diabetic in a low income country: a cross sectional study","volume":"3","author":"Kattel V","year":"2019","unstructured":"Kattel V, Subedi M, Agrawal Y, et al.. Cost of illness study of regular out patient department diabetic in a low income country: a cross sectional study. J Diabetes Endocrinol Assoc Nepal. 2019, 3:16-25. 10.3126\/jdean.v3i1.24060","journal-title":"J Diabetes Endocrinol Assoc Nepal"},{"key":"ref16","unstructured":"Enhancing diabetes prevention through lifestyle modifications in Idaho. (2024). Accessed. October 3, 2025: https:\/\/www.proquest.com\/openview\/dd873d84632b93234286fcba80f75c1b\/1?pq-origsite=gscholar&amp;cbl=18750&amp;diss=y."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(23)00132-8","article-title":"Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial","volume":"11","author":"Zhang L","year":"2023","unstructured":"Zhang L, Zhang Y, Shen SA, et al.. Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial. Lancet Diabetes Endocrinol. 2023, 11:567-77. 10.1016\/S2213-8587(23)00132-8","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2015.01.027","article-title":"Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions","volume":"107","author":"Stevens JW","year":"2015","unstructured":"Stevens JW, Khunti K, Harvey R, et al.. Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions. Diabetes Res Clin Pract. 2015, 107:320-31. 10.1016\/j.diabres.2015.01.027","journal-title":"Diabetes Res Clin Pract"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2011.01512.x","article-title":"Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patients","volume":"14","author":"Esposito K","year":"2012","unstructured":"Esposito K, Chiodini P, Bellastella G, Maiorino MI, Giugliano D. Proportion of patients at HbA1c target &lt;7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patients. Diabetes Obes Metab. 2012, 14:228-33. 10.1111\/j.1463-1326.2011.01512.x","journal-title":"Diabetes Obes Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/409481-a-longitudinal-multicenter-study-comparing-the-effectiveness-of-pharmacological-and-lifestyle-only-interventions-in-adults-with-prediabetes-for-preventing-acute-hyperglycemic-crises-and-progression-to-type-2-diabetes-mellitus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:12:26Z","timestamp":1761466346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/409481-a-longitudinal-multicenter-study-comparing-the-effectiveness-of-pharmacological-and-lifestyle-only-interventions-in-adults-with-prediabetes-for-preventing-acute-hyperglycemic-crises-and-progression-to-type-2-diabetes-mellitus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,26]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.95420","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,26]]}}}